Rybelsus: available as an oral semaglutide option for patients who prefer tablets over injections
doi: 10.1021/acs.jafc.5b00244, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 83
It seems that chemotherapy regimens (drug or combination of drugs administered and dosing), methods of pain assessment and the individual patient characteristics (presence of comorbidities associated with increased risk of neuropathy, such as diabetes, depression, insomnia or genetic particularities) are some of the several factors that may influence on the onset of CIPN and the severity of symptoms
By slowing gastric emptying, enhancing satiety, and reducing hunger, GLP-1s help individuals feel fuller for longer periods, which can reduce overall calorie intake and support weight loss
Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury